Abstract
Purpose
Fixed bulky nodal disease in patients with head and neck cancer of unknown primary (HNCUP) remains difficult to treat. This retrospective study evaluated the therapeutic efficacy of selective intra-arterial chemoradiotherapy with docetaxel and nedaplatin for fixed bulky nodal disease in HNCUP.
Methods
Data from seven consecutive patients with fixed bulky nodal disease in HNCUP who had undergone selective intra-arterial chemoradiotherapy were analyzed. Whole pharyngeal mucosa and all bilateral nodal areas were irradiated (total dose 50 Gy), and bulky nodal lesions were provided an additional 20 Gy. Intra-arterial chemotherapy used a combination of nedaplatin (80 mg/m2) and docetaxel (60 mg/m2). Outcome measures were local control, disease-free survival, overall survival, and adverse events. Statistical analyses were performed using the Kaplan–Meier method.
Results
Median follow-up period was 24 months (range 9–64). All patients had extracapsular extension (N3b) on imaging and clinical findings. Symptoms due to bulky disease were neck discomfort (100%), tumor bleeding (43%), tracheal obstruction (14%), and carotid sinus syndrome (28%). Median value for maximum diameter of cervical disease was 84 mm (range 70–107), and 3-year local control, disease-free survival, and overall survival rates were 100, 54, and 64%, respectively. Symptoms due to bulky disease disappeared in all patients after intra-arterial chemoradiotherapy. Grade 4 leukopenia occurred in two patients (28%) as an acute adverse event. No other serious acute adverse events were observed.
Conclusion
Selective intra-arterial chemoradiotherapy with docetaxel and nedaplatin can potentially achieve both favorable local control and survival in in HNCUP with fixed bulky nodal disease.
Similar content being viewed by others
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Miller FR, Karnad AB, Eng T, Hussey DH, Stan McGuff H, Otto RA (2008) Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy. Head Neck 30:28–34. https://doi.org/10.1002/hed.20654
Waltonen JD, Ozer E, Hall NC, Schuller DE, Agrawal A (2009) Metastatic carcinoma of the neck of unknown primary origin: evolution and efficacy of the modern workup. Arch Otolaryngol Head Neck Surg 135:1024–1029. https://doi.org/10.1001/archoto.2009.145
National Comprehensive Cancer Network (NCCN) Clinical practice guidelines in oncology. Head and neck cancers, version 2.2020. http://www.nccn.org. Accessed 9 Nov 2020
Johnson CR, Khandelwal SR, Schmidt-Ullrich RK, RavaleseWazer JDE (1995) The influence of quantitative tumor volume measurements on local control in advanced head and neck cancer using concomitant boost accelerated superfractionated irradiation. Int J Radiat Oncol Biol Phys 32:635–641. https://doi.org/10.1016/0360-3016(95)00031-S
Dubben HH, Thames HD, Beck-Bornholdt HP (1998) Tumor volume: a basic and specific response predictor in radiotherapy. Radiother Oncol 47:167–174. https://doi.org/10.1016/s0167-8140(97)00215-6
Chan JY, To VS, Wong ST, Wei WI (2013) Quality of dying in head and neck cancer patients: the role of surgical palliation. Eur Arch Otorhinolaryngol 270:681–688. https://doi.org/10.1007/s00405-012-2059-7
Johnstone C, Lutz ST (2014) The role of hypofractionated radiation in the management of non-osseous metastatic or uncontrolled local cancer. Ann Palliat Med 3:291–303. https://doi.org/10.3978/j.issn.2224-5820.2014.10.01
Robbins KT, Wong FS, Kumar P, Hartsell WF, Vieira F, Mullins B, Niell HB (1999) Efficacy of targeted chemoradiation and planned selective neck dissection to control bulky nodal disease in advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 125:670–675. https://doi.org/10.1001/archotol.125.6.670
Robbins KT, Kumar P, Wong FS, Hartsell WF, Flick P, Palmer R, Weir AB 3rd, Neill HB, Murry T, Ferguson R, Hanchett C, Vieira F, Bush A, Howell SB (2000) Targeted chemoradiation for advanced head and neck cancer: analysis of 231 patients. Head Neck 22:687–693. https://doi.org/10.1002/1097-0347(200010)22:7%3c687::aid-hed8%3e3.0.co;2-w
Yabuuchi H, Kuroiwa T, Tajima T, Tomita K, Ochiai N, Kawamoto K (2003) Efficacy of intra-arterial infusion therapy using a combination of cisplatin and docetaxel for recurrent head and neck cancers compared with cisplatin alone. Clin Oncol 15:467–472. https://doi.org/10.1016/j.clon.2003.07.003
Maeda A, Toh S, Higaki Y, Tomita K (2003) Super-selective intra-arterial infusion chemotherapy for oral cancer. Stomato Pharyngol 15:345–351. https://doi.org/10.14821/stomatopharyngology1989.15.345
Kobayashi W, Teh BG, Sakaki H, Sato H, Kimura H, Kakehata S, Nagahata M (2010) Superselective intra-arterial chemoradiotherapy with docetaxel-nedaplatin for advanced oral cancer. Oral Oncol 46:860–863. https://doi.org/10.1016/j.oraloncology.2010.10.001
Balaker AE, Abemayor E, Elashoff D, St John MA (2012) Cancer of unknown primary: does treatment modality make a difference? Laryngoscope 122:1279–1282. https://doi.org/10.1002/lary.22424
Argiris A, Smith SM, Stenson K, Mittal BB, Pelzer HJ, Kies MS, Haraf DJ, Vokes EE (2003) Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary. Ann Oncol 14:1306–1311. https://doi.org/10.1093/annonc/mdg330
Nieder C, Gregoire V, Ang KK (2001) Cervical lymph node metastases from occult squamous cell carcinoma: cut down a tree to get an apple? Int J Radiat Oncol Biol Phys 50:727–733. https://doi.org/10.1016/s0360-3016(01)01462-6
Jereczek-Fossa BA, Jassem J, Orecchia R (2004) Cervical lymph node metastases of squamous cell carcinoma of unknown primary. Cancer Treat Rev 30:153–164. https://doi.org/10.1016/j.ctrv.2003.10.001
Cheraghlou S, Torabi SJ, Husain ZA, Otremba MD, Osborn HA, Mehra S, Yarbrough WG, Burtness BA, Judson BL (2019) HPV status in unknown primary head and neck cancer: prognosis and treatment outcomes. Laryngosope 129:684–691. https://doi.org/10.1002/lary.27475
Spring PM, Valentino J, Arnold SM, Sloan D, Kenady D, Kudrimoti M, Haydon RC, Lee C, Given C, Mohiuddin M, Regine WF (2005) Long-term results of hyperfractionated radiation and high-dose intraarterial cisplatin for unresectable oropharyngeal carcinoma. Cancer 104:1765–1771. https://doi.org/10.1002/cncr.21368
Dreyfuss A, Clark J, Norris C, Rossi RM, Lucarini JW, Busse PM, Poulin MD, Thornhill L, Costello R, Posner MR (1996) Docetaxel: an active drug for squamous cell carcinoma of the head and neck. J Clin Oncol 14:1672–1678. https://doi.org/10.1200/JCO.1996.14.5.1672
Schoffski P, Catimel G, Planting AS, Droz JP, Verweij J, Schrijvers D, Gras L, Schrijvers A, Wanders J, Hanauske AR (1999) Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group. Ann Oncol 10:119–122
Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, Stewart JS, Jelic S, Betka J, Preiss JH, van den Weyngaert D, Awada A, Cupissol D, Kienzer HR, Rey A, Desaunois I, Bernier J, Lefebvre JE, EORTC 24971/TAX 323 Study Group (2007) Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357:1695–1704. https://doi.org/10.1056/NEJMoa071028
Posner MR, Glisson B, Frenette G, Al-Sarraf M, Colevas AD, Norris CM, Seroskie JD, Shin DM, Olivares R, Garay CA (2001) Multicenter phase I-IItrialI–IItrial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck. J Clin Oncol 19:1096–1104. https://doi.org/10.1200/JCO.2001.19.4.1096
Harper CS, Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ, Million RR (1990) Cancer in neck nodes with unknown primary site: role of mucosal radiotherapy. Head Neck 12:463–469. https://doi.org/10.1002/hed.2880120603
Colletier PJ, Garden AS, Morrison WH, Goepfert H, Geara F, Ang KK (1998) Postoperative radiation for squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site: outcomes and patterns of failure. Head Neck 20:674–681. https://doi.org/10.1002/(sici)1097-0347(199812)20:8%3c674::aid-hed3%3e3.0.co;2-h
Strojan P, Anicin A (1998) Combined surgery and postoperative radiotherapy for cervical lymph node metastases from an unknown primary tumor. Radiother Oncol 49:33–40. https://doi.org/10.1016/s0167-8140(98)00082-6
Grau C, Johansen LV, Jakobsen J, Geertsen P, Andersen E, Jensen BB (2000) Cervical lymph node metastases from unknown primary tumors: results from a national survey by the Danish society for head and neck oncology. Radiother Oncol 55:121–129. https://doi.org/10.1016/s0167-8140(00)00172-9
Suoglu Y, Erdamar B, Katircioglu OS, Karatay MC, Sunay T (2002) Extracapsular spread in ipsilateral neck and contralateral neck metastases in laryngeal cancer. Ann Otol Rhinol Laryngol 111:447–454. https://doi.org/10.1177/000348940211100510
Issing WJ, Taleban B, Tauber S (2003) Diagnosis and management of carcinoma of unknown primary in the head and neck. Eur Arch Otorhinolaryngol 260:436–443. https://doi.org/10.1007/s00405-003-0585-z
Eisbruch A, Harris J, Garden AS, Chao CK, Straube W, Harari PM, Sanguineti G, Jones CU, Bosch WR, Ang KK (2010) Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00–22). Int J Radiat Oncol Biol Phys 76:1333–1338. https://doi.org/10.1016/j.ijrobp.2009.04.011
Maghami E, Ismaila N, Alvarez A, Chernock R, Duvvuri U, Geiger J, Gross N, Haughey B, Paul D, Rodriguez C, Sher D, Stambuk HE, Waldron J, Witek M, Caudell J (2020) Diagnosis and management of squamous cell carcinoma of unknown primary in the head and neck: ASCO guideline. J Clin Oncol 38:2570–2596. https://doi.org/10.1200/JCO.20.00275
Heianna J, Yamashita Y, Iraha Y, Murayama S (2020) A rare case of cerebral hemorrhage associated with intra-arterial infusion chemotherapy for advanced sphenoid sinus cancer. J Can Res Ther 16:686–689. https://doi.org/10.4103/jcrt.JCRT_1444_16
Acknowledgements
We would like to thank Keiichi Nishimaki, Chief of Neurosurgery, Akita Red Cross Hospital, and Satoshi Takahashi, Associate Professor of Radiology, Akita University School of Medicine, for useful discourse on neuro-interventional radiology.
Funding
No funding from any source was received in association with this work.
Author information
Authors and Affiliations
Contributions
JH, WM, KI, and ST were responsible for the conceptualization. JH, WM, HM, and TA designed the study. HH and SA were responsible for use of the patient-reported outcomes following initial treatment. JH and HT were responsible for data curation and formal analysis. JH was responsible for ethics approval and writing the original draft. SM was responsible for supervision. All authors contributed to patient inclusion and manuscript writing and editing.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no relationships with any companies whose products or services may be related with the subject matter of the article.
Ethical approval
This single-center retrospective study was approved by the ethics committee of the University of Ryukyus for Medical and Health Research Involving Human Subjects (reference number: 1443) and was conducted in accordance with the principles of the Declaration of Helsinki.
Consent to participate
This study was retrospective in nature, the requirement for written informed consent from the patients was waived.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Heianna, J., Makino, W., Hirakawa, H. et al. Therapeutic efficacy of selective intra-arterial chemoradiotherapy with docetaxel and nedaplatin for fixed bulky nodal disease in head and neck cancer of unknown primary. Eur Arch Otorhinolaryngol 279, 3105–3113 (2022). https://doi.org/10.1007/s00405-021-07121-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-021-07121-9